56 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
14 May 24
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
7:45am
and the period in which Xilio expects to have cash to fund its operations; and Xilio’s strategy, goals and anticipated financial performance
8-K
EX-99.1
4vhyvny v9j
1 Apr 24
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
4:15pm
8-K
EX-99.1
4kb 9uzp457s
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
y01r2h6c
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-99.2
p42i3him7 10dac2
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-99.1
mhi6t
7 Dec 23
Other Events
7:45am
8-K
eew19p8 z8ax3jy
7 Dec 23
Other Events
7:45am
8-K
EX-99.1
k3llyddub902r8v bsu
9 Nov 23
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
4:13pm
8-K
uk1d1eyjn
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
8bzgvorkubl2h
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
2fc40q8tdapibm8nxr
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.1
jmdf 6mbmsegp
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.2
onpak
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am